<DOC>
	<DOCNO>NCT01769872</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety autologous transplantation Adipose Tissue derive Mesenchymal stem cell ( MSCs ) patient spinal cord injury</brief_summary>
	<brief_title>Safety Effect Adipose Tissue Derived Mesenchymal Stem Cell Implantation Patients With Spinal Cord Injury</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>Subjects understand sign consent form study Age : 1970 Clinical diagnosis spinal cord injury ( American Spinal Injury Association [ ASIA ] Impairment Scale [ AIS ] grade A B C ) Duration injury : &gt; 3 month Subjects must put respirator Subjects malignant tumor within 5 year Subjects infectious disease include HIV hepatitis Subjects injure brain spinal cord spinal cord injury Subjects anemia thrombocytopenia Subjects angina pectoris , myocardial infarction , cardiomyopathy , occlusive disease , chronic renal failure , glomerular disease chronic obstructive pulmonary disease Subjects congenital acquire immunodeficiency disorder Patients cloud consciousness speech disorder treat cytotoxic medication ( immunosuppressive drug , corticosteroid cytotoxic drug ) clinical trial participate another clinical trial within 3 month serious disease disorder could seriously affect ability participate study</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>